A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois

Study Identifier
H20-308
CT.gov Identifier
NCT04611230
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Infections & Vaccines - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Currently living or employed in Lake County, Illinois. * Have regular access to computer, smartphone or tablet and sufficient internet access to connect to study platform. * Willing and able to provide informed consent for collection of online data and of respiratory and blood specimens. * Willing and able to follow the procedures of the study. * Able to complete survey in English or Spanish.
    Exclusion Criteria:
    * Unable to provide informed consent. * Unable to perform the requested study tasks and unable or unwilling to assign a proxy informant to complete the tasks. * Hospitalized at the time of study enrollment.

    Protocol Summary

    Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Lung failure is the main cause of death related to COVID-19 infection. The main objective of this study is to assess infection of SARS-CoV-2 and how quality of life is affected in adult volunteers in Lake County, Illinois.

    Volunteers will be recruited through digital advertisements and participants will be required to fill an online questionnaire. Upon consent, participants will be required to provide nasal swab and blood sample. Approximately 1250 adult volunteers living or working in Lake County, IL will be enrolled.

    Participants will be followed for approximately 9 months and will be required to provide nasal swab and blood samples every 3 months and complete questionnaires every 2 weeks.

    There may be higher treatment burden for participants in this trial. Participants will be monitored by medical assessments, blood tests and questionnaires.

    Study Locations

    Location
    Status
    Location
    Great Lakes Clinical Trials /ID# 224874
    Chicago, Illinois, United States, 60640
    Status
    Not applicable